LSBCF (LakeShore Biopharma Co) Revenue: $86.09 Mil (TTM As of Mar. 2025)


What is LakeShore Biopharma Co Revenue?

LakeShore Biopharma Co LSBCF Revenue is $86.09 Mil as of Mar. 2025.

LakeShore Biopharma Co's revenue for the six months ended in Mar. 2025 was $33.52 Mil. Its revenue for the trailing twelve months (TTM) ended in Mar. 2025 was $86.09 Mil. LakeShore Biopharma Co's Revenue per Share for the six months ended in Mar. 2025 was $1.74. Its Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2025 was $4.50.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

LakeShore Biopharma Co  (OTCPK:LSBCF) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.

Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.

LakeShore Biopharma Co Revenue Related Terms

LakeShore Biopharma Co Revenue Historical Data

* Premium members only.

The historical data trend for LakeShore Biopharma Co's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LakeShore Biopharma Co Revenue Chart

LakeShore Biopharma Co Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25
Revenue
39.48 79.27 99.73 79.63 84.83

LakeShore Biopharma Co Semi-Annual Data
Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25
Revenue Get a 7-Day Free Trial Premium Member Only 41.75 37.42 41.70 52.56 33.52

LSBCF vs ACUT, PPCB, ENSC: Revenue Comparison

For the Biotechnology subindustry, LakeShore Biopharma Co's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

LakeShore Biopharma Co Revenue vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, LakeShore Biopharma Co's Revenue distribution charts can be found below:

* The bar in red indicates where LakeShore Biopharma Co's Revenue falls into.


LakeShore Biopharma Co Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Mar. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $86.09 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Revenue →
What does a Revenue of $86.09 Mil mean?
LakeShore Biopharma Co (LSBCF) has a Revenue of $86.09 Mil as of Mar. 2025. Revenue is the total amount a company generates as sales through its operations. View historical data on LakeShore Biopharma Co and its competitors.
Is LakeShore Biopharma Co's Revenue too high?
LakeShore Biopharma Co's current Revenue is $86.09 Mil.
How does LakeShore Biopharma Co's Revenue compare to ACUT and PPCB?
LakeShore Biopharma Co's Revenue of $86.09 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue for a Biotechnology company?
A good Revenue depends on the Biotechnology industry context. However, Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue mean?
A high Revenue can signal that a stock is expensive relative to its fundamentals. Revenue is the total amount a company generates as sales through its operations. View historical data on LakeShore Biopharma Co and its competitors. LakeShore Biopharma Co's current Revenue is $86.09 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LakeShore Biopharma Co stock overvalued right now?
LakeShore Biopharma Co (LSBCF) has a current Revenue of $86.09 Mil. The current Revenue is $86.09 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue calculated?
Revenue is calculated from a company's financial statements. For LakeShore Biopharma Co (LSBCF), the current Revenue is $86.09 Mil as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

LakeShore Biopharma Co Business Description

Address 38 Yongda Road, Building No. 2, Daxing Biomedical Industry Park, Daxing District, Beijing, CHN, 102629
LakeShore Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. The company operates in China, the United States, Singapore, and the Philippines.